Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 123 clinical trials
Premie DCD Imaging Intervention Study

Participants will have a 2nd MRI 12 weeks after the first scan. They will then receive 12 weekly sessions with an occupational therapist, followed by a third MRI.

  • 0 views
  • 19 Feb, 2024
Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand

Eligible patients have prostate cancer that was treated with surgery or radiation therapy for localized disease and there is evidence of biochemical recurrence and/or metastases on conventional imaging.The objective of this study is to assess the performance in detection of prostate cancer of a new positron emission tomography (PET) radiotracer …

metastasis
positron emission tomography
fluciclovine (18f)
localized disease
MRI
  • 0 views
  • 19 Feb, 2024
Hyperpolarized Imaging for New Treatments

Inhalation of a hyperpolarized gas enables the visualization and quantification of regional ventilation in the lung and can be combined with structural MRI to assess both structure and function in parallel. The main Investigator and others have recently formed an international consortium (the 129Xe MRI Clinical Trial Consortium), comprised of …

antibiotic therapy
multiple breath washout
pilocarpine
cystic fibrosis transmembrane conductance regulator
antibiotics
  • 0 views
  • 19 Feb, 2024
EBRT and HDR Brachytherapy for Unfavorable-intermediate High and Very High-risk Prostate Cancer

This study is trying to find out if the combination of Androgen deprivation therapy (ADT), MRI guided high dose radiation (HDR) brachytherapy treatment (internal radiation implant procedure) and external beam radiation therapy (EBRT) treatments lead to less side effects.

digital rectal exam
prostate adenocarcinoma
androgens
pelvic mri
adenocarcinoma of prostate
  • 0 views
  • 19 Feb, 2024
Self-Control in Bulimia Nervosa

Data will be collected using questionnaires and a technology called magnetic resonance imaging (MRI).

bulimia
fasting
MRI
  • 0 views
  • 19 Feb, 2024
ELUCIDATE: Enabling LUng Cancer IDentification Using folATE Receptor Targeting

This is a phase 3, multi-center, single dose, open-label, exploratory study in suspected lung cancer patients scheduled to undergo endoscopic or thoracic surgery per CT/PET/MRI or other imaging based on standard of care. This study aims to assess the efficacy of OTL38 and Near Infrared Imaging (NIR) at identifying pulmonary …

wedge excision
thoracoscopy
cancer
thoracic surgery
lung cancer
  • 0 views
  • 19 Feb, 2024
Predictors of Response in Chronic Stroke

This study will validate a predictive model that uses demographics, functional status, neurophysiology, neuroanatomy, and other potential biomarkers to predict the likelihood of a clinically significant change in impairment at the end of a robot assisted therapy intervention.The study will include magnetic resonance imaging (MRI), transcranial magnetic stimulation (TMS), and …

arm exercises
chronic stroke
transcranial magnetic stimulation
arm exercise
stroke
  • 0 views
  • 19 Feb, 2024
5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:

Stereotactic Ablative Body Radiotherapy (SABR) given in 5 weekly fractions. Simultaneously treating the pelvic lymph nodes, prostate and MRI-nodule to a total dose of 25 Gy, 35 Gy and up to 50 Gy, respectively. The radiation will be given with 6-18 months of ADT. 5-fraction SABR is a feasible, well-tolerated, …

adenocarcinoma
adenocarcinoma of prostate
stereotactic body radiation therapy
  • 0 views
  • 19 Feb, 2024
Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma

Patients with unequivocal recurrence (first or greater) established by MRI and meeting inclusion and exclusion criteria, will be eligible for OKN-007 treatment on this protocol.

  • 0 views
  • 19 Feb, 2024
Minocycline in MS: Confirmation of Benefit

Trial participants will include men and women, aged 18-60 years who have had a first demyelinating event within the previous 180 days and who have brain magnetic resonance imaging (MRI) with at least two brain T2 lesions which are at least 3 mm in diameter, and at least one of …

mri brain
multiple symptoms
MRI
demyelination
oligoclonal bands
  • 0 views
  • 19 Feb, 2024